Gefitinib
Inquiry
| Post Date: | Feb 04,2015 |
| Expiry Date: | Feb 04,2016 |
| Detailed Description: |
Cas No. :184475-35-2
Product name: Gefitinib
CAS: 184475-35-2 Molecular formula: C22H24ClFN4O3 Molecular weight: 446.9 Description: Gefitinib (trade name Iressa, marketed by AstraZeneca and Teva), is a drug used for certain breast, lung and other cancers. Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells. Therefore, it is only effective in cancers with mutated and overactive EGFR. |
| CAS Registry Number: | 184475-35-2 |
| Synonyms: | ;GEFITINIB;AKOS 91371;n-(3-chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine;N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine;ZD 1839;4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-;Gefitinib(TINIBS);Gefitinib, Iressa, ZD1839;Gefitinib Base;Geftinib; |
| Molecular Formula: | C22H24ClFN4O3 |
| Molecular Weight: | 446.9024 |
| Molecular Structure: | 
|
| Company: | AUSMAUCO BIOTECH CO., LIMITED [ China ] |
| Contact: | john |
| Tel: | +8618060810639 |
| Fax: | |
| Email: | plantsale@aus-bio.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
